Peninsula biotech unloads SoCal cell therapy manufacturing facility for $100M

Atara Biotherapeutics Inc. will sell its cell manufacturing center in Thousand Oaks, California, for $100 million to a unit of Japanese conglomerate Fujifilm. The deal for the 90,000-square-foot facility adds enough cash to South San Francisco-based Atara's (NASDAQ: ATRA) coffers to fund operations into late 2023, while Fujifilm...

Click to view original post